02.10.2015 Views

studies

2015SupplementFULLTEXT

2015SupplementFULLTEXT

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

418A AASLD ABSTRACTS HEPATOLOGY, October, 2015<br />

Univariate analysis compared baseline factors.Baseline factors<br />

independently associated with HD after TACE were identified<br />

with Cox regression. Results:51 patients(28%)experienced an<br />

HD event within 90 days of TACE.Median time to decompensation<br />

event after first TACE was 52 days.On univariate analysis,<br />

alkaline phosphatase(ALP), total bilirubin(TB), albumin,<br />

INR, MELD, being within Milan or UCSF criteria, history of<br />

HD event within 1 year of TACE significantly differed between<br />

decompensated and compensated groups(TABLE).Cox regression<br />

model identified a decompensation event within 1 year<br />

prior to TACE(HR 2.19,p=0.02), ALP(HR 1.003,p=0.007)and<br />

being outside UCSF criteria(HR 0.49,p=0.02)as independently<br />

associated with an HD event after TACE.TB, albumin, INR and<br />

MELD were not. Conclusion:For patients with cirrhosis being<br />

considered for TACE, absence of decompensating event within<br />

1 year of TACE, HCC within UCSF criteria and low ALP are<br />

associated with low risk of TACE-related HD.<br />

Univariate Analysis<br />

Disclosures:<br />

The following authors have nothing to disclose: Dempsey Hughes, Fredric D.<br />

Gordon, Keith E. Stuart, FW Nugent, Sebastian Flake, Mary Ann Simpson, Amir<br />

A. Qamar<br />

between pathological and radiological findings regarding<br />

the number of nodules was found in 103/184(56%): 78<br />

were underestimated and 25 overestimated by radiology.<br />

10/40(25%) patients who were within Milan criteria, resulted<br />

outside according to histology due to discrepancy in number<br />

of nodules. Considering the diameter of the biggest nodule on<br />

explant, discordance was observed in 158/181(87%): 93<br />

were underestimated and 65 overestimated. 20 of 40(50%)<br />

within Milan criteria on imaging, exceeded these due to<br />

discrepancy in biggest nodule diameter. HCC recurrence<br />

occurred in 29/184(16%) patients in a median of 37m (4-157)<br />

post-LT. In Cox regression, pre-LT factors associated with HCC<br />

recurrence were aFP>100 IU/ml (p3cm<br />

(p3cm but different<br />

aFP levels (22% in aFP100, p=0.003).<br />

The same pre-LT factors were also significantly associated with<br />

HCC-related mortality post-LT. Conclusion: In HCC transplanted<br />

patients there was a marked discrepancy between radiological<br />

findings and pathological description of the explant. The best<br />

predictors of HCC recurrence were pre-LT aFP and diameter<br />

of the biggest nodule. Combined together could allow us to<br />

include in the current transplant criteria patients with biggest<br />

nodule diameter>3cm if aFP

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!